Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Dawn M. George"'
Autor:
Dawn M George, Raymond J Huntley, Kevin Cusack, David B Duignan, Michael Hoemann, Jacqueline Loud, Regina Mario, Terry Melim, Kelly Mullen, Gagandeep Somal, Lu Wang, Jeremy J Edmunds
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203567 (2018)
The ability to restrict low molecular weight compounds to the gastrointestinal (GI) tract may enable an enhanced therapeutic index for molecular targets known to be associated with systemic toxicity. Using a triazolopyrazine CSF1R inhibitor scaffold,
Externí odkaz:
https://doaj.org/article/f9e4d7a1ef864cb18c1b355c36fdb091
Autor:
Kevin P. Cusack, David B. Duignan, Jacqueline Loud, Michael Z. Hoemann, Lu Wang, Kelly D. Mullen, Regina Mario, Jeremy J. Edmunds, Dawn M. George, Gagandeep Somal, Raymond Huntley, Terry Melim
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203567 (2018)
PLoS ONE
PLoS ONE
The ability to restrict low molecular weight compounds to the gastrointestinal (GI) tract may enable an enhanced therapeutic index for molecular targets known to be associated with systemic toxicity. Using a triazolopyrazine CSF1R inhibitor scaffold,
Autor:
Anwar Murtaza, Edit Tarcsa, Ana L. Aguirre, Neil Wishart, Gagandeep Somal, Lu Wang, Kent D. Stewart, Stacy Van Epps, Kristine E. Frank, Heather Davis, Michael Friedman, Bin Li, Jeffrey W. Voss, Maria A. Argiriadi, Jonathan George, Morytko Michael J, Jeremy J. Edmunds, Dawn M. George, Deborah Hyland, Kevin R. Woller, Eric R. Goedken, Bryan A. Fiamengo
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 25:4399-4404
Previous work investigating tricyclic pyrrolopyrazines as kinase cores led to the discovery that 1-cyclohexyl-6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazine (12) had Jak inhibitory activity. Herein we describe our initial efforts to develop orally b
Publikováno v:
2017 Medicinal Chemistry Reviews ISBN: 9780996293242
2017 Medicinal Chemistry Reviews
2017 Medicinal Chemistry Reviews
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70771c78568846fa9eda0c9f9a7d42dd
https://doi.org/10.29200/acsmedchemrev-v52.ch9
https://doi.org/10.29200/acsmedchemrev-v52.ch9
Autor:
Stacy Van Epps, Dawn M. George
Publikováno v:
Bioactive Heterocyclic Compound Classes: Pharmaceuticals
Autor:
Jose-Andres Salmeron, Kevin P. Cusack, Dawn M. George, Thomas D. Gordon, Michael Friedman, Bernd Janssen, Agnieszka Bischoff, Claude Barberis, Woller Kevin R, Yong Jia, Neil Wishart, Shannon R. Fix-Stenzel, Richard W. Dixon, Christopher Quinn, Maria A. Argiriadi, Zhengtian Yu, Anca Clabbers, Hamish Allen, Maria D Moskey
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:4952-4955
Evaluation of hit chemotypes from high throughput screening identified a novel series of 2,4-disubstituted thieno[2,3-c]pyridines as COT kinase inhibitors. Structural modifications exploring SAR at the 2- and 4-positions resulting in inhibitors with
Autor:
Pratima Bansal-Pakala, David B. Duignan, QingYu Lang, Lian Rundell, Eric C. Breinlinger, Jianfei Wang, Scott W. Mittelstadt, Yang Zhang, Annette Schwartz, Jiakang Sun, Maria A. Argiriadi, P. Honore, Jeremy J. Edmunds, Dawn M. George
Publikováno v:
Journal of medicinal chemistry. 58(1)
We previously demonstrated that selective inhibition of protein kinase Cθ (PKCθ) with triazinone 1 resulted in dose-dependent reduction of paw swelling in a mouse model of arthritis.1,2 However, a high concentration was required for efficacy, thus
Autor:
Lian Rundell, Dominique Potin, Martine Barth, Yang Zhang, Jianfei Wang, Pratima Bansal-Pakala, Michael Friedman, Maria A. Argiriadi, QingYu Lang, David B. Duignan, Eric C. Breinlinger, Scott W. Mittelstadt, Jeremy J. Edmunds, Dawn M. George, P. Honore
Publikováno v:
Journal of medicinal chemistry. 58(1)
Protein kinase Cθ (PKCθ) regulates a key step in the activation of T cells. On the basis of its mechanism of action, inhibition of this kinase is hypothesized to serve as an effective therapy for autoimmune diseases such as rheumatoid arthritis (RA
Autor:
Stacy Van Epps, Dawn M. George
Publikováno v:
ChemInform. 44
Identification of a selective thieno[2,3-c]pyridine inhibitor of COT kinase and TNF-alpha production
Autor:
Pintipa Grongsaard, Yong Jia, Andres Salmeron, Christine M. Thomas, Richard W. Dixon, Grier A. Wallace, Michael Friedman, Dawn M. George, Hamish Allen, Agnieszka Bischoff, Zhengtian Yu, Thomas D. Gordon, Bernd Janssen, Maria D Moskey, Shannon R. Fix-Stenzel, Christopher Quinn, Yvette Gaumont, Kevin P. Cusack, Neil Wishart, Anca Clabbers
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(6)
COT (Tpl2 in mice) is a serine/threonine MAP3 kinase that regulates production of TNF-alpha and other pro-inflammatory cytokines such as IL-1beta via the ERK/MAP kinase pathway. As TNF-alpha and IL-1beta are clinically validated targets for therapeut